1 | Bupropion | Bupropion [4] Bupropion; Bupropion & citalopram; Bupropion hydrochloride; Wellbutrin (bupropion); | [3] D00817 D00817
D07591 D07591
D07938 D07938 💬 |
[2] SLC6A2, SLC6A3 💬 |
Alcoholism [7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
008 [5] 8 , 18, 21, 96, 171 💬 |
2 | Caffeine | Caffeine [6] Caffeine; Caffeine 100 mg; Caffeine 100-200 mg bid; Caffeine alkaloid; Dextromethorphan and caffeine; Other: caffeine; | [2] D00528 D00528
D01453 D01453 💬 |
[11] ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism [22] Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 [9] 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
3 | Cysteamine | Cystagon (cysteamine bitartrate) immediate-release capsules [13] Cystagon (cysteamine bitartrate) immediate-release capsules; Cystagon® (cysteamine bitartrate); Cysteamine; Cysteamine (mercaptamine) viscous solution; Cysteamine bitartrate; Cysteamine bitartrate (cystagon); Cysteamine bitartrate (inn: mercaptamine bitartrate; Cysteamine bitartrate (inn: mercaptamine bitartrate ); Cysteamine bitartrate (inn: mercaptamine bitartrate); Cysteamine bitartrate delayed-release capsules; Cysteamine bitartrate delayed-release capsules (rp103); Cysteamine hydrochloride; Other: cysteamine bitartrate; | [2] D03634 D03634
D03635 D03635 💬 |
- |
- |
008 [4] 8 , 19, 21, 299 💬 |
4 | Dexmedetomidine | Dexmedetomidine [10] Dexmedetomidine; Dexmedetomidine 1; Dexmedetomidine 2; Dexmedetomidine 3; Dexmedetomidine group; Dexmedetomidine hydrochloride; Dexmedetomidine hydrochloride infusion; Dexmedetomidine with ropivacaine; Fentanyl (low dose) + dexmedetomidine; Scopolamine, atropine, edaravone and dexmedetomidine; | [2] D00514 D00514
D01205 D01205 💬 |
[3] ADRA2A, ADRA2B, ADRA2C 💬 |
Neuroactive ligand-receptor interaction [2] Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway |
002 [12] 2 , 4 , 6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬 |
5 | Dextromethorphan | Dextromethorphan [10] Dextromethorphan; Dextromethorphan 30 mg; Dextromethorphan and caffeine; Dextromethorphan hbr and quinidine sulfate; Dextromethorphan hydrobromide; Dextromethorphan hydrobromide 20 mg and quinidine sulfate 10 mg; Dextromethorphan hydrobromide 30 mg and quinidine sulfate 10 mg; Dextromethorphan/quinidine; Dextromethorphan/quinidine 20mg/10mg (dm/q 20mg/10mg); Dimebon + dextromethorphan; | [3] D00848 D00848
D03742 D03742
D03744 D03744 💬 |
[6] GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism [20] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 [11] 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
6 | Elamipretide | Elamipretide [4] Elamipretide; Elamipretide (high dose); Elamipretide (intermediate dose); Elamipretide (low dose); | [1] D10925 D10925 💬 |
- |
- |
021 [2] 21, 324 💬 |
7 | Flurbiprofen | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) [3] Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Flurbiprofen; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; | [3] D00330 D00330
D01475 D01475
D02290 D02290 💬 |
[2] PTGS1, PTGS2 💬 |
Alzheimer disease [23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
013 [3] 13, 21, 46 💬 |
8 | Haemagglutinin-strain B | - | - |
- |
- |
021 [4] 21, 46, 49, 50 💬 |
9 | Influenza A virus A/Brisbane/59/2007 (H1N1) antigen (formaldehyde inactivated) | - | - |
- |
- |
021 [2] 21, 49 💬 |
10 | Influenza A virus A/California/7/2009 X-179A (H1N1) antigen (formaldehyde inactivated) | - | - |
- |
- |
021 [2] 21, 49 💬 |
11 | Influenza A virus A/Switzerland/9715293/2013 NIB-88 (H3N2) antigen (formaldehyde inactivated) | - | - |
- |
- |
021 [2] 21, 49 💬 |
12 | Influenza A virus A/Texas/50/2012 X-223A (H3N2) antigen (formaldehyde inactivated) | - | - |
- |
- |
021 [2] 21, 49 💬 |
13 | Influenza A virus A/Uruguay/716/2007(H3N2) antigen (formaldehyde inactivated) | - | - |
- |
- |
021 [2] 21, 49 💬 |
14 | Influenza A virus A/Victoria/210/2009 X-187 (H3N2) antigen (formaldehyde inactivated) | - | - |
- |
- |
021 [2] 21, 49 💬 |
15 | Influenza A virus A/Victoria/361/2011 IVR-165 (H3N2) antigen (formaldehyde inactivated) | - | - |
- |
- |
021 [2] 21, 49 💬 |
16 | Influenza B virus B/Brisbane/60/2008 antigen (formaldehyde inactivated) | - | - |
- |
- |
021 [2] 21, 49 💬 |
17 | Influenza B virus B/Massachusetts/2/2012 antigen (formaldehyde inactivated) | - | - |
- |
- |
021 [2] 21, 49 💬 |
18 | Influenza B virus B/Massachusetts/2/2012 BX-51B antigen (formaldehyde inactivated) | - | - |
- |
- |
021 [2] 21, 49 💬 |
19 | Influenza B virus B/Phuket/3073/2013 antigen (formaldehyde inactivated) | - | - |
- |
- |
021 [2] 21, 49 💬 |
20 | Influenza B virus B/Texas/6/2011 antigen (formaldehyde inactivated) | - | - |
- |
- |
021 [2] 21, 49 💬 |
21 | Midazolam | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) [7] Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Midazolam; Midazolam 2 mg; Midazolam 3 mg; Midazolam injection; Montelukast, flurbiprofen, midazolam, digoxin, pravastatin and bms-986142; S-ketamine & midazolam; | [3] D00550 D00550
D00696 D00696
D05028 D05028 💬 |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 [11] 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
22 | Omeprazole | Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin) [19] Bms drug-drug interaction cocktail (montelukast, flurbiprofen, omeprazole, midazolam, and digoxin); Clartihromycin, amoxicillin, and omeprazole; Diclofenac + omeprazole; Dimebon + omeprazole; Esomeprazole; Esomeprazole 20 mg; Naproxen 500 mg tablets (pn 200 minus omeprazole); Nexium (esomeprazole magnesium); Omeprazole; Omeprazole (uk licensed generic product); Omeprazole 20 mg; Omeprazole 20mg; Omeprazole 20mg bid; Omeprazole 40 mg; Omeprazole 40mg capsule; Omeprazole magnesium; Omeprazole rectally 1mg/kg; Pn 200 tablets (500 mg naproxen and 20 mg omeprazole); Rifaximin+omeprazole+miralax; | [4] D00455 D00455
D01207 D01207
D05259 D05259
D05261 D05261 💬 |
[2] ATP4A, ATP4B 💬 |
Collecting duct acid secretion [4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 [16] 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
23 | Propofol | Device: propofol dosage [5] Device: propofol dosage; Intubated with propofol (ip); Procedure: sedation with iv propofol; Propofol; Propofol-lipuro; | [1] D00549 D00549 💬 |
[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
006 [9] 6 , 21, 22, 34, 46, 75, 84, 98, 296 💬 |
24 | Repaglinide | Repaglinide [2] Repaglinide; Repaglinide and insulin; | [1] D00594 D00594 💬 |
[2] ABCC8, KCNJ11 💬 |
ABC transporters [4] ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus |
006 [3] 6 , 21, 299 💬 |
25 | Sevoflurane | Intubated with sevoflurane (is) [3] Intubated with sevoflurane (is); Sevoflurane; Sevoflurane anesthetics; | [1] D00547 D00547 💬 |
- |
- |
006 [6] 6 , 21, 22, 34, 98, 296 💬 |
26 | Sonlicromanol | Sonlicromanol [1] Sonlicromanol; | - |
- |
- |
021 [1] 21 💬 |
27 | Uridine triacetate | - | [1] D09985 D09985 💬 |
- |
- |
021 [1] 21 💬 |
28 | Vatiquinone | Vatiquinone [1] Vatiquinone; | [1] D10407 D10407 💬 |
- |
- |
018 [2] 18, 21 💬 |